Subject: interim analysis will not qualify for pharm. Раздел в протоколе клинического исследования:Premature Termination of the Trial/Trial Site If after the termination of the trial the risk/benefit analysis has changed, the new evaluation should be provided to the IEC/IRB in case it will have an impact on the planned follow-up of the subjects who have participated in the trial. If so, the actions needed to protect the subjects should be described. The planned interim analysis will not qualify for a premature termination of the trial. Подскажите, пожалуйста, как перевести "interim analysis will not qualify for" в последнем предложении. |
Вопрос о досрочном завершении исследования не будет решаться по результатам промежуточного анализа |
спасибо! |
You need to be logged in to post in the forum |